These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7768249)

  • 1. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ; Jansen JB; Jebbink MC; Masclee AA; Rovati LC; Lamers CB
    Eur J Clin Pharmacol; 1995; 47(6):489-92. PubMed ID: 7768249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
    Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
    Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K; Arai M; Omachi H; Mitamura K
    J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J; Niederau M; Lüthen R; Niederau C
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
    Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
    Jebbink MC; Masclee AA; van der Kleij FG; Schipper J; Rovati LC; Jansen JB; Lamers CB
    Hepatology; 1992 Oct; 16(4):937-42. PubMed ID: 1398500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man.
    Beglinger C; Hildebrand P; Adler G; Werth B; Luo H; Delco F; Gyr K
    Eur J Clin Invest; 1992 Dec; 22(12):827-34. PubMed ID: 1282465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC; Jansen JB; Masclee AA; Lamers CB
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.
    Douglas BR; Jebbink MC; Tjon a Tham RT; Jansen JB; Lamers CB
    Eur J Pharmacol; 1989 Jul; 166(2):307-9. PubMed ID: 2792196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two new cholecystokinin antagonists on gallbladder emptying in opossums.
    Hanyu N; Dodds WJ; Layman RD; Hogan WJ; Colton DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G258-64. PubMed ID: 1996645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.